Physician profile
Christopher Ryan Stetler
NPI 1891725537
$1,316.73
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,047 · 2020: $224 · 2021: $16.42 · 2022: $13.48 · 2023: $16.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $269.96 | 2019-2020 | |
| Novo Nordisk INC | $135.00 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $131.72 | 2019 | |
| Pfizer INC. | $129.36 | 2019 | |
| Allergan, INC. | $127.35 | 2019-2020 | |
| Abbvie INC. | $76.99 | 2019-2023 | Vraylar |
| Amarin Pharma, INC. | $57.37 | 2019-2020 | |
| Lilly USA, LLC | $53.97 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.07 | 2019 | |
| Amgen INC. | $44.81 | 2019 | |
| Jazz Pharmaceuticals INC. | $38.77 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $35.32 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $25.60 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.71 | 2019-2020 | |
| Antares Pharma, INC. | $24.20 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $20.78 | 2020 | |
| Dermira, INC. | $18.52 | 2019 | |
| Adlon Therapeutics L.P. | $14.26 | 2019 | |
| Amneal Pharmaceuticals LLC | $13.64 | 2019 | |
| Ironshore Pharmaceuticals INC. | $12.50 | 2019 | |
| Glaxosmithkline, LLC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Stetler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.